Latest Life Sciences News

Page 13 of 15
ALS Limited reported a robust FY25 with $3 billion revenue driven by Life Sciences growth and resilient Commodities, announcing a $350 million equity raise to fund strategic expansion.
Victor Sage
Victor Sage
27 May 2025
ALS Limited reported a 16% revenue increase to nearly $3 billion in FY2025, driven by acquisitions and organic growth, while underlying net profit after tax dipped slightly. The company announced a $350 million equity raise to fund expansion and sustainability initiatives.
Victor Sage
Victor Sage
27 May 2025
TruScreen Group Ltd reports a dip in FY25 sales but forecasts a robust rebound in FY26 driven by resumed programs and expansion in key emerging markets. Strategic partnerships and AI-enabled technology underpin its growth ambitions.
Ada Torres
Ada Torres
26 May 2025
Microba Life Sciences reveals breakthrough data showing its MetaPanel™ test detects elusive gastrointestinal pathogens in 20% of chronic cases, enabling targeted treatment and complete symptom resolution.
Ada Torres
Ada Torres
21 May 2025
Lendlease has partnered with The Crown Estate to create a 50/50 joint venture aimed at accelerating capital recycling of over $300 million through UK commercial and residential developments. The deal also includes a $1.2 billion Australian office investment mandate, boosting Lendlease’s funds under management to $20 billion.
Eva Park
Eva Park
19 May 2025
Microba Life Sciences reveals preliminary data from over 4,600 MetaXplore GI Plus tests showing significant clinical findings in the majority of patients, with two-thirds reporting symptom improvements following test-guided care.
Ada Torres
Ada Torres
14 May 2025
EZZ Life Science Holdings Limited has announced a fully franked ordinary dividend of AUD 0.02 per share for the six months ending December 2024, signaling steady returns for shareholders.
Ada Torres
Ada Torres
6 May 2025
Microba Life Sciences reported robust Q3 FY25 growth in its microbiome diagnostic tests, led by MetaXplore and MetaPanel, while advancing its therapeutics pipeline and projecting strong full-year revenue growth.
Ada Torres
Ada Torres
30 Apr 2025
Microba Life Sciences reports robust growth in microbiome diagnostic testing across Australia and the UK, while advancing US market entry plans and transitioning its Therapeutics business to a partnering model.
Ada Torres
Ada Torres
30 Apr 2025
AnteoTech Ltd reports progress in advanced battery and life sciences technologies alongside a strategic review and leadership changes amid challenging EV market conditions.
Sophie Babbage
Sophie Babbage
30 Apr 2025
Vitrafy Life Sciences reported strong Q3 FY2025 progress, including a successful US Army blood platelet study, a $4.8 million government grant, and strategic US market expansion.
Ada Torres
Ada Torres
29 Apr 2025
Lendlease Group has reported a robust turnaround in its half-year results, posting an operating profit after tax of $122 million and advancing its strategic capital recycling initiatives. The company is on track to reduce gearing and enhance operational efficiency amid ongoing market challenges.
Eva Park
Eva Park
17 Feb 2025